Total hip replacement but not clinical osteoarthritis can be predicted by shape variations of the hip: a prospective cohort study (check)  by Agricola, R. et al.
Table 1
Cartilage loss (mm) in cases with knee replacement (KR) and matched controls
KLG2 KLG3 KLG4
KR
Cases
Matched
Controls
KR
Cases
Matched
Controls
KR
Cases
Matched
Controls
cMFTC Median -0.15 +0.03 -0.17 -0.12 -0.08 -0.09
Mean -0.57 0.00 -0.26 -0.12 -0.12 -0.09
MFTC Median -0.07 +0.01 -0.13 -0.08 -0.07 -0.05
Mean -0.26 +0.03 -0.18 -0.09 -0.07 -0.05
OV1 Median -0.27 -0.14 -0.29 -0.22 -0.24 -0.20
Mean -0.59 -0.15 -0.37 -0.24 -0.28 -0.25
KR¼ knee replacement; KLG¼ Kellgren Lawrence grade; (c)MFTC¼ (central) medial
femorotibial compartment; OV ¼ ordered value
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S12dwarﬁsm with impaired matrix degradation of the cartilage primordia
due to decrease of Mmp13 expression, while Sox9-Cre;Hes1ﬂ/ﬂ
embryos exhibited normal sketetal growth. When we created the
experimental OA model in TM-inducible knockout mice, the knee OA
development was suppressed in both Col2a1-CreTM;Rbpjﬂ/ﬂ mice and
Sox9-Cre;Hes1ﬂ/ﬂ mice as compared to the respective control litter-
mates, with prevention of the terminal stage of endochondral ossiﬁ-
cation. ATDC5 cells overexpressing Notch1-ICD showed enhanced
expression of Mmp13 and Hes1 in one-week pellet culture. Further-
more, the enhancement of Mmp13 expressionwas partially canceled by
inhibition of Hes1 expression though the speciﬁc siRNA transfection.
Luciferase analyses revealed that the Hes1 transfection enhanced the
MMP13 promoter activity most potently among the Hes/Hey members.
Conclusion: The Notch/Rbpj/Hes1 signal in chondrocytesmodulates OA
development by induction of MMP13, indicating it as a possible ther-
apeutic target of OA.
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Purpose: Knee OA has been shown to reduce quality of life and increase
health care utilization. In the absence of disease modifying drugs
(DMOADs), knee replacements (KR) are projected to increase to over 3
million annually in the US by 2030. Imaging biomarkers capable of
predicting relevant clinical endpoints, such as KR, may be valuable tools
for testing the efﬁcacy of DMOADs in clinical trials. The purpose of this
study was thus to examine whether MRI-based longitudinal measures
of cartilage loss predict knee replacement, whether prediction differs by
radiographic disease stage, and whether ordered values (OVs) of
subregional cartilage change provide a better prediction than region-
speciﬁc measures.
Methods: Knees from Osteoarthritis Initiative (OAI) participants who
received a KR between 12 and 48 month follow-up (conﬁrmed by
radiography and/or review of hospital records) were studied. One
matched control knee was selected for each KR case from OAI partici-
pants with the same Kellgren Lawrence (KL) grade at baseline (central
X-ray readings strata 0-1, 2, 3, 4), with the same sex and age (within 5 y),
who did not receive a KR during this period. Quantitative measures of
cartilage were obtained from a sagittal 3T DESSwe MRI sequence. The
time point prior to the occurrence of a KR (T0) and that 12 months
earlier (T-1) were analyzed. Segmentation of weight-bearing femoroti-
bial cartilage was performed by 12 readers (Chondrometrics GmbH,
Ainring, Germany) with blinding to acquisition order. Cartilage thick-
ness (ThCtAB) was determined in 16 subregions. The central medial
compartment (cMFTC) was selected as primary endpoint, the total
medial compartment (MFTC) as secondary endpoint, and OVs as
exploratory endpoints. P-values for differences in cartilage loss between
case/control pairs were computed using the Wilcoxon signed rank test,
and AUCs (with adjustment for matching variables) using ROC analysis.
Results: 191 knees of 165 OAI participants received a KR, of whom 109
had central X-ray readings at the time of analysis, MRI data at both T0
and T-1, and a matched control (46 men, 63 women, age 63.88.9, BMI
29.95.0). Longitudinal cartilage loss (Table 1) in cMFTC (p¼0.007,
AUC¼0.59) and MFTC (p¼0.014, AUC¼0.58), over a 12 month period
prior to KR, discriminated signiﬁcantly between KR cases and controls.
Discrimination for cMFTC was greater in KLG2 (n¼20; p¼0.009;
AUC¼0.67) than in KLG3 (n¼39; p¼0.16; AUC¼0.55) or KLG4 (n¼45;
p¼0.65; AUC¼0.54).
OV1 (the subregion with maximal loss in each knee independent of
location) tended to discriminate better between KRs and controls overall
(p¼0.0006, AUC¼0.63) and in KLG2 (p¼0.004, AUC¼0.79) and KLG3
knees (p¼0.02; AUC¼0.62) compared to cMFTC, but the differences in
AUCs did not reach statistical signiﬁcance. OVs 1 through 8 differed
signiﬁcantly between KRs and controls, whereas only 3 (of the 16)
subregions showed signiﬁcant differences between KR and control knees.Conclusions: Quantitative MRI measures of cartilage thickness loss
predict KR, particularly at the earlier stages of radiographic knee OA.
Point estimates for AUCs suggest that OV1 performs better in predicting
KRs than location speciﬁc measures, but with current sample size the
differences did not reach statistical signiﬁcance. The use of OV1
circumvents the need to choose a speciﬁc region a priori as a primary
endpoint and/or to adjust for comparing multiple regions of interest.
Quantitative measures of cartilage loss may be used in clinical trials to
demonstrate efﬁcacy of DMOADs. Also, the current ﬁndings support the
concept that treatments that slowcartilage lossmaydelayor prevent KR.
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TOTAL HIP REPLACEMENT BUT NOT CLINICAL OSTEOARTHRITIS CAN
BE PREDICTED BY SHAPE VARIATIONS OF THE HIP: A PROSPECTIVE
COHORT STUDY (CHECK)
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J. Waarsing 1. 1 Erasmus Med. Ctr., Rotterdam, Netherlands; 2Delft Univ.
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Purpose: Osteoarthritis (OA) of the hip can be deﬁned by both radio-
graphic and clinical criteria. Previously, it has been shown that radio-
graphic criteria associate to the shape of the hip. However, it is
unknown whether shape variations of the hip also associate with hip
OA deﬁned by clinical criteria. We aimed to determine the contribution
of hip shape in the prediction of both end-stage OA (THR) and general
clinical OA (ACR criteria) in a prospective cohort.
Methods: Individuals were extracted from the CHECK (cohort hip and
cohort knee) study. CHECK is a prospective cohort study of individuals
with assumed early symptomatic OA of knee or hip. Of the 1002 indi-
viduals, a random subset of 865 had standardized anteroposterior
radiographs (AP) taken at both baseline and 5 years follow-up. AP-pelvic
radiographs of sufﬁcient qualitywere obtained in 723 subjects at baseline
and in 770 subjects at 5 years follow-up. The shape of the proximal femur
and acetabulum on the AP radiographs was assessed using statistical
shapemodelling (SSM). The shapewasdeﬁnedbya set of landmarkpoints
that are positioned along the contour of the bone in the image (Figure 1).
An SSM describes all variation in shape of the complete cohort by several
independent shape aspects calledmodes. Hips that had received TotalHip
Replacement (THR) within 5 years were classiﬁed as end-stage OA and
hips fulﬁlling the ACR criteria after 5 years based on history, physical
examination, and laboratory ﬁndings were classiﬁed as clinical OA. The
association between each mode and both outcome measures was calcu-
lated by Generalized Estimating Equations (GEE), corrected for sex and
age. To correct for multiple testing, a p-value of 0.0017 was used to
determine statistical signiﬁcance (0.05 was divided by the 30 modes
tested). The predictive value of the GEE model including all univariate
signiﬁcantmodeswas then tested by the area under the ROC curve (AUC).
Results: For this study, 682 females (meanage 55.8) and183males (mean
age 56.4) were included. At baseline, 75% of the hips had no signs of OA
(K&L¼0) whereas 25% had doubtful OA (K&L¼1).When corrected for age
and sex, nine modes at baseline associated signiﬁcantly with the devel-
opment of end-stage OA within 5 years (Table 1). For example, mode 12
which resulted in the largest odds ratio of 2.34, illustrates superior joint
space narrowing and overcoverage of the acetabulum. When combining
thesemodes, only the four modes which associatedmost with end-stage
OA (mode 4, 11, 12, 15) were selected for calculating the AUC, to prevent
overﬁtting of the model. The predictive value of those four modes in the
GEE model resulted in an AUC of 0.81. At baseline, no modes associated
signiﬁcantly with the presence of clinical OA at 5 years.
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by an SSM is able to predict the risk of THR, whereas variation in shape
can not predict the development of clinical OA. The latter might be
a result of the poor reliability of the ACR criteria. We observed that 87%
of the individuals who had clinical OA at baseline, did not have clinical
OA anymore after 5 years. In conclusion, minor shape variations at
baseline have a good predictive value for the development of end-stage
OA and may be used as a biomarker to predict the future risk for THR.8
ASSESSMENT OF PERFUSION IN OSTEOARTHRITIS INDUCED BONE
MARROW LESIONS USING DYNAMIC CONTRAST ENHANCED
MAGNETIC RESONANCE IMAGING
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Purpose: Osteoarthritis (OA) is the most common joint disease in
modern, aging societies and causes substantial physical and psycho-
social disability. During the initiation and progression of OA, sub-
chondral bone is the site of numerous dynamic morphological
transformations due to an altered osteoblast metabolism, which is part
of the pathological process. These in situ structural changes in sub-
chondral bone can be readily observed using imaging techniques such
as fat suppressed T2-weighted MRI during the course of OA. Whilst
previous studies in the OA literature support a link between BMLs and
knee pain, few have evaluated bone perfusion in relation to knee pain in
OA. This study characterizes BML in OA by assessing perfusion in
Ăsubchondral bone with dynamic contrast-enhanced (DCE) MRI. Corre-
lation of imaging parameters wasmadewith BML grade and size as well
as WOMAC pain subscores.
Methods: There were 37 participants with moderate to severe knee OA
(mean 64.9 years, range 46 to 86) with radiographic Kellgren and Law-
rencegradesof 3 and4. Themeanpain subscale of the Likert versionof the
WOMAC index was 10.3 (0-20 scale). Subjects had an MRI performed of
their knee on a 1.5T Twin Speed GE Excite scanner with a dedicated knee
coil. BML localization was performed using a sagittal dual echo FSE fat
suppressed sequencewithTR/TEof 4000ms/15ms, 60ms, 2.5- 3mmslices,
no skip/gap, 256X256matrix and 12 cm FOV. Each BMLwas graded from
0-3 on the basis of lesion size according to the BLOKS scoring system.
Gadolinium-diethylenetriaminepenta -acetic acid (Gd-DTPA) was
injected at a standard concentration (0.1 mmol/kg) using a power
injector followed by a saline ﬂush. Dynamic contrast enhanced (DCE)
MRI was performed using a 3D FSPGR sequence with 20 sagittal slices of
3 mm thickness over 7 minutes with a 7.5 second time resolution with
a TR/TE of 5.5ms/2.9ms with a 12 degree ﬂip angle and 256x128 matrix.
Subchondral BMLs were identiﬁed on T2W fat suppressed images as
discrete areas of increased signal adjacent to subcortical bone and used
for DCE-MRI perfusion analysis. A pharmacokinetic model was used to
analyze perfusion parameters using in-house software to model transfer
rates into and out of the BMLs using adjacent areas of muscle as internal
controls. The relation between perfusion and pain was evaluated using
multivariate linear regression and its relationship with pain at night
was performed using ordinal logistic regression separately after
adjustment for BML grade, age, gender and BMI.
Results: There was a signiﬁcant correlation between BML kel /Muscle kel
(rate of contrast elimination) and BML grade (p¼0.001/0.002 in uni/
multivariate analyses). No signiﬁcant associationwas foundbetweenBML
DCE-MRI perfusionparameters and pain or pain at night.Moreover, BMLs
Grades 1 and2 had small volumes compared to the total joint volume and
may not contribute to the overall knee pain. An inverse relationship was
also foundbetweenpainatnightandBMLgradedetermined fromthepre-
contrast T2W fat suppressed images (p<0.05). However, our ﬁndings
indicated that the larger BMLs had a positive kel (more normal clearance)
indicating more normative venous outﬂow and less pain.
Conclusion: BMLs are formed from various causes, all of which may be
interacting and complex and comprised of biomechanical, genetic and
inﬂammatory components which contribute to the genesis of pain. OA
is a dynamic disease process with interconnecting symptoms and
structural changes and measurement of bone perfusion highlights only
one of these factors. Ascertaining which structures in the knee with OA
are associated with pain will aid our understanding of the pathophys-
iology of OA and lead to the development of more effective therapeutic
options to delay disease progression.
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PREVALENCE OF MEDIOPATELLAR PLICA IN SUBJECTS WITH KNEE
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DAMAGE AND BONE MARROW LESIONS: THE JOG STUDY
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Purpose: Osteoarthritis (OA) commonly occurs in the patellofemoral
joint (PFJ) and knee pain in subjects with knee OA often emanates from
the PFJ rather than the tibiofemoral joint (TFJ). Despite this, research
into risk factors and mechanisms for PFJ OA is limited compared to that
of the TFJ. Mediopatellar plica (MPP) is often observed in conjunction
with patello-femoral structural damage and plica syndrome is
a common cause of knee pain. However, it is largely unclear if MPP is an
independent risk factor for structural PFJ damage or if MPP is an inci-
dental ﬁnding of questionable relevance.
Thus, the aimwas to describe the frequency of different types of MPP in
a cohort of subjects with knee pain and to assess the cross-sectional
association of plica with cartilage damage and bone marrow lesions
(BMLs) in the PFJ after adjustment for demographic and anatomical
variants that increase risk of PF structural damage
Methods: The JOG study is a double-blind randomized trial investigating
the effect of oral glucosamine supplementation over a 6 months period.
177 subjects aged 35-65 with chronic, frequent knee painwere included.
3 T MRI (Siemens Trio) of both knees was performed at baseline and 6
months FU using the same pulse sequence protocol as in the Osteoar-
thritis Initiative. A total of 342 knees were included. MPP was scored as
